Top Dems Mount Pressure On Becerra To Reverse COVID-19 LDT Policy Stopping FDA Oversight
Source : Medtech Insight
Top US House Democrats have asked the Department of Health and Human Services (HHS) to reverse a Trump administration policy to stop the Food and Drug Administration from reviewing COVID-19...
Enforcement Comeback? FDA Budget Predicts Eye-Popping 1,767% Increase In US Inspections In FY ’22
Source : Medtech Insight
A budget request for the US Food and Drug Administration released by the White House on 28 May predicts that domestic GMP inspections...
Greater adverse outcomes in patients presenting with COVID-19 and STEMI
Source : https://www.cardionewsuk.org/?p=578
The goal of the NACMI (North American COVID-19 and STEMI) registry is to describe demographic characteristics, management strategies, and outcomes of COVID-19 patients with STEMI. Methods A prospective, ongoing observational...
Drugmakers’ recent earnings reveal the secondary but serious health effects of the pandemic, from delayed cancer screenings to reduced surgeries.
COVID-19: FDA Schedules 4 More Virtual Town Halls Through May
Source : Medtech Insight
The US Food and Drug Administration is continuing its run of virtual town halls aimed at labs and manufacturers that are (or have) developed diagnostic tests for COVID-19.
The FDA announced...